Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carmel S. Verrier"'
Autor:
Jasgit C. Sachdev, Jessica N. Snider, Jeffrey W. Allen, Lee S. Schwartzberg, Robyn R. Young, Ahmed Y. Javed, Matthew P. Smeltzer, Furhan Yunus, Carmel S. Verrier, Mohammad Jahanzeb
Publikováno v:
Journal of Cancer and Allied Specialties, Vol 2, Iss 1 (2016)
Purpose: This phase II neoadjuvant study investigated whether nab paclitaxel, carboplatin and bevacizumab given before neoadjuvant doxorubicin/cyclophosphamide (AC) produced higher pathologic complete response (pCR) rates in triple- negative breast c
Externí odkaz:
https://doaj.org/article/167a5538fb324c858a09f1c7b1d521a1
Autor:
Craig B Bennett, Tammy J Westmoreland, Carmel S Verrier, Carrie A B Blanchette, Tiffany L Sabin, Hemali P Phatnani, Yuliya V Mishina, Gudrun Huper, Alice L Selim, Ernest R Madison, Dominique D Bailey, Adebola I Falae, Alvaro Galli, John A Olson, Arno L Greenleaf, Jeffrey R Marks
Publikováno v:
PLoS ONE, Vol 3, Iss 1, p e1448 (2008)
BRCA1 has been implicated in numerous DNA repair pathways that maintain genome integrity, however the function responsible for its tumor suppressor activity in breast cancer remains obscure. To identify the most highly conserved of the many BRCA1 fun
Externí odkaz:
https://doaj.org/article/4bc481118f46427cb111886447c1d4de
Autor:
Kimberly Blackwell, Carmel S. Verrier
Publikováno v:
Breast Cancer: Translational Therapeutic Strategies ISBN: 1420019945
Breast Cancer: Translational Therapeutic Strategies
Breast Cancer: Translational Therapeutic Strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::916a10f17657df51350825ae5bf389c9
https://doi.org/10.3109/9781420019940.017
https://doi.org/10.3109/9781420019940.017
Autor:
Jasgit C. Sachdev, Furhan Yunus, Jeffrey Warren Allen, Mohammad Jahanzeb, Jessica N. Snider, Ahmed Y. Javed, Lee S. Schwartzberg, Carmel S. Verrier, Robyn R. Young
Publikováno v:
Journal of Clinical Oncology. 31:1068-1068
1068 Background: TNBC are mostly “basal-like” tumors, that have been shown to overexpress Secreted Protein Acidic and Rich in Cysteine (SPARC). Endothelial transcytosis of nab-P via albumin- gp60 -cav1 and binding of albumin to SPARC results in h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b19faa9d11079fe911187fa4b0f7a094
https://doi.org/10.1200/jco.2013.31.15_suppl.1068
https://doi.org/10.1200/jco.2013.31.15_suppl.1068
Autor:
Arno L. Greenleaf, Adebola I. Falae, Alice L. Selim, Carrie Blanchette, Ernest R. Madison, John A. Olson, Alvaro Galli, Carmel S. Verrier, Gudrun Huper, Jeffrey R. Marks, Hemali Phatnani, Tammy J. Westmoreland, Yuliya V. Mishina, Tiffany L. Sabin, Craig B. Bennett, Dominique D. Bailey
Publikováno v:
PLoS ONE, Vol 3, Iss 1, p e1448 (2008)
PLoS ONE
PLoS ONE
BRCA1 has been implicated in numerous DNA repair pathways that maintain genome integrity, however the function responsible for its tumor suppressor activity in breast cancer remains obscure. To identify the most highly conserved of the many BRCA1 fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba5db9936b0c194f81d562489ffd57f
https://doi.org/10.1371/journal.pone.0001448
https://doi.org/10.1371/journal.pone.0001448
Autor:
Furhan Yunus, Jasgit C. Sachdev, Ahmed Y. Javed, Mohammad Jahanzeb, Matthew P. Smeltzer, Robyn R. Young, Jessica N. Snider, Jeffrey W. Allen, Carmel S. Verrier, Lee S. Schwartzberg
Publikováno v:
Journal of Cancer and Allied Specialties, Vol 2, Iss 1 (2016)
Purpose: This phase II neoadjuvant study investigated whether nab paclitaxel, carboplatin and bevacizumab given before neoadjuvant doxorubicin/cyclophosphamide (AC) produced higher pathologic complete response (pCR) rates in triple- negative breast c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0126f6e7c210612c7e34e3ab7cd349b3
https://doi.org/10.37029/jcas.v2i1.59
https://doi.org/10.37029/jcas.v2i1.59